nimodipine has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegg, CC | 1 |
| Hu, S | 1 |
| Peterson, PK | 1 |
| Thayer, SA | 1 |
2 other studies available for nimodipine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia.
Topics: Acquired Immunodeficiency Syndrome; Brain; Calcium; Calcium Channel Blockers; Calcium Channels, L-Ty | 2000 |
[Drug for the control of stroke may help AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Humans; Nimodipine | 1990 |